SAN DIEGO, Sept. 5, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of ...
“It has always been IMU’s focus to be an innovative global centre of excellence in learning and research, which is why we are always ready to team up with experts in the field of technology – ...
IMU Biosciences and Waters Corporation announced a strategic partnership to accelerate the development of IMU’s next-generation AI-powered High Definition (HD) Immunology platform. The partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results